We are pleased to announce that our third product of bovine vaccine has been approved by the United Arab Emirates (UAE) authority and its first batch has been launched in the market this month.

Now our three bovine vaccines are registered and available in UAE, namely "KYOTOBIKEN„ CATTLEWIN-5K ("KYOTOBIKEN" CATTLEWIN 5 COMBO INACTIVATED VACCINE, for the bovine respiratory diseases), BOVINE EPHEMERAL FEVER VACCINE・K-KB ("KYOTOBIKEN" BOVINE EPHEMERAL FEVER INACTIVATED VACCINE), and "KYOTOBIKEN" CALFWIN 6 COMBO LIVE VACCINE (also for the bovine respiratory diseases) in this time.

Taking this opportunity, our president (Toru Onishi) visited our valued partner, GAH Veterinary Medicine (Headquarter: Dubai in UAE, General Manager: Dr. Mohamed Hussein), as the KYOTOBIKEN distributor for our "MENA" markets, and join the signature ceremony for the renewed contract.

At the same time, a commemorative clock was presented to appreciate excellent achievements by GAH and the best partnership between these two companies.

This clock shows each local time of three key cities where GAH and KYOTOBIKEN are located, Dubai in UAE, Cairo in Egypt and Kyoto in Japan.

GAH and KYOTOBIKEN will launch the above three products in other "MENA" countries, as one of the most important regions for our international business strategy, and we are excited to expect that our products could be used to support many farms there.